Search Results

Atosiban 50mg 50mg  | Purity Not Available

Adooq Bioscience

Atosiban is a peptide Oxytocin Receptor Inhibitor.

More Information Supplier Page

×

Atosiban 50mg

Atosiban 25mg 25mg  | Purity Not Available

Adooq Bioscience

Atosiban is a peptide Oxytocin Receptor Inhibitor.

More Information Supplier Page

×

Atosiban 25mg

Atosiban 10mg 10mg  | Purity Not Available

Adooq Bioscience

Atosiban is a peptide Oxytocin Receptor Inhibitor.

More Information Supplier Page

×

Atosiban 10mg

Jasmonic acid 50mg 50mg  | Purity Not Available

Adooq Bioscience

Jasmonic acid is derived from the fatty acid linolenic acid.

More Information Supplier Page

×

Jasmonic acid 50mg

Jasmonic acid 25mg 25mg  | Purity Not Available

Adooq Bioscience

Jasmonic acid is derived from the fatty acid linolenic acid.

More Information Supplier Page

×

Jasmonic acid 25mg

Jasmonic acid 100mg 100mg  | Purity Not Available

Adooq Bioscience

Jasmonic acid is derived from the fatty acid linolenic acid.

More Information Supplier Page

×

Jasmonic acid 100mg

JNJ-31020028 5mg 5mg  | Purity Not Available

Adooq Bioscience

JNJ-31020028 is a selective, high affinity, receptor antagonist existing as a racemic mixture.

More Information Supplier Page

×

JNJ-31020028 5mg

JNJ-31020028 25mg 25mg  | Purity Not Available

Adooq Bioscience

JNJ-31020028 is a selective, high affinity, receptor antagonist existing as a racemic mixture.

More Information Supplier Page

×

JNJ-31020028 25mg

JNJ-31020028 10mg 10mg  | Purity Not Available

Adooq Bioscience

JNJ-31020028 is a selective, high affinity, receptor antagonist existing as a racemic mixture.

More Information Supplier Page

×

JNJ-31020028 10mg

NLG919 10mM * 1mL in DMSO 10mM * 1mL in DMSO  | Purity Not Available

Adooq Bioscience

NLG919 is an orally available inhibitor of indoleamine 2,3-dioxygenase 1 (IDO1), with potential immunomodulating and antineoplastic activities.

More Information Supplier Page

×

NLG919 10mM * 1mL in DMSO